Table 4. EGF-Receptor expression.
Patient | Culture condition | EGFR (%) | Viability (%) | Proliferation (%) | |
---|---|---|---|---|---|
Day 0 | Day 7 | Day 7 | Day 7 | ||
22 | EGF 50 | 90 | 100 | 30 | 70 |
80 | 60 | 50 | |||
24 | Hydrocortisone | 80 | 70 | 70 | 10 |
40 | 80 | 60 | 25 | ||
26 | Folic acid 6 | 80 | 70 | 30 | 30 |
80 | |||||
29 | EGF 50 | 50 | 20 | 50 | 30 |
40 | 10 | 90 | 2 | ||
30 | EGF 50 | 90 | 10 | 50 | 0 |
90 | 5 | 30 | 30 | ||
73 | EGF 50 | 100 | 80 | 70 | 10 |
90 | 5 | 30 | 0 | ||
74 | EGF 50 | 95 | 40 | 30 | 30 |
50 | 40 | 20 |
Raw percentage of positive EGFR expression at day 0 and day 7.